Dilipshanghvi is a prominent figure in his segment in today's Indian pharmaceutical industry. Dilipshanghvi has reached a high level in the production of medicines. He is the creator of Sun Pharmaceutical Industries, who runs a pharmaceutical empire worth around $30 billion.

His dedication and business plan beat his competitor Mukesh Ambani to become the most successful businessman in India. Sun Pharma recently acquired Ranbaxy Laboratories, adding more luster to its already shiny armour.

Dilipshanghvi bought Sun Pharmaceutical Industries in 1982 for Rs. 10,000 and founded Vapi. The example is inspiring because his story is a testament to the idea that a goal can be achieved by taking a small step forward.

Born in 1955 in a family of few in Gujarat. Shanghvi graduated from Calcutta University with a degree in Commerce. He was a wholesale drug dealer in Kolkata. He was a drug distributor, but he realized that the job was more profitable and satisfying by creating his own drugs and selling them instead of selling other people's drugs. That was the seed for Sun Pharma, founded in 1982 by two marketing experts and five psychiatry drugs. In the early days, only a few pharmaceutical companies in the world were producing these drugs because their products were popular.

Without many doctors prescribing these drugs, the production of these products by Sun Pharma is just to showcase their presence in the market. Sun Pharma is now India's largest pharmaceutical company, with 25 manufacturing plants across four continents. Sun Pharma is the 5th largest producer of complex generics globally. Sun Pharma has grown to become the largest pharmaceutical company in its US market, growing by acquiring companies almost every year.

Under Dilipshanghvi's direction, Sun Pharmaceuticals continued its expansion and joint ventures with various European and US drug companies. 2012 was a year of significant change, in which the company acquired two US businesses, URL PharmaInc and DUSA Pharmaceuticals Inc. The acquisition of Israel-based Taro created Sun as a major player in international markets and helped Dilipshanghvi succeed in the industry. .

While the United States is actually a large source of solar revenue, there is good scope for expansion there. Shanghvi is currently focusing on specific areas of the market to continue the expansion of Sun Pharmaceuticals. In addition to focusing on dermatology products, Shanghvi Company will focus on improving business in Europe.

Shanghvi's personal story and journey of incredible success are inspiring in many ways Born into a humble family, he never put limits on his goals, never allowed his circumstances to limit or stop him from pursuing his dreams and achieving his dreams.

Additionally, he didn't chase fantasy dreams by being strong and smart and climbed the ladder of success through persistent dedication, passion and determination, all of which resulted in an enlightening finale. Additionally, he never once accepted the negative comments of critics or those who claimed it was impossible or impossible. He believed in his abilities and focused on his strengths and he accepted defeats and losses with a smile and truly enjoyed the fruits of his labor.